about
French multicentre clinical evaluation of helical TomoTherapy for anal cancer in a cohort of 64 consecutive patientsFrequency and risk factors for malnutrition in children undergoing general anaesthesia in a French university hospital: A cross-sectional observational study.Patient satisfaction with breasts and psychosocial, sexual, and physical well-being after breast augmentation in male-to-female transsexuals.Assessment of Liver Disease Progression in cystic Fibrosis Using Transient Elastography.Double-hit or dual expression of MYC and BCL2 in primary cutaneous large B-cell lymphomas.The SCD-Well randomized controlled trial: Effects of a mindfulness-based intervention versus health education on mental health in patients with subjective cognitive decline (SCD)The Age-Well randomized controlled trial of the Medit-Ageing European project: Effect of meditation or foreign language training on brain and mental health in older adultsThe Age-Well observational study on expert meditators in the Medit-Ageing European projectAssessment of diagnostic criteria between primary cutaneous anaplastic large-cell lymphoma and CD30-rich transformed mycosis fungoides; a study of 66 casesWalking and psychomotor speed in the elderly: concordance, correlates and prediction of deathA Single-Arm Phase II Trial of Lenalidomide in Relapsing or Refractory Primary Cutaneous Large B-Cell Lymphoma, Leg TypeOrgan preservation with chemoradiotherapy plus local excision for rectal cancer: 5-year results of the GRECCAR 2 randomised trialDiabetes-Associated Dementia Risk and Competing Risk of Death in the Three-City StudyImpact of an intervention to support hearing and vision in dementia: The SENSE-Cog Field TrialPrimary cutaneous large B-cell lymphomas: relevance of the 2017 World Health Organization classification: clinicopathological and molecular analyses of 64 casesFeasibility of an Intervention to Support Hearing and Vision in Dementia: The SENSE-Cog Field TrialMutations of the B-Cell Receptor Pathway Confer Chemoresistance in Primary Cutaneous Diffuse Large B-Cell Lymphoma Leg TypePrognostic factors for cancer patient admitted to a medical intensive care unit
P50
Q36009950-4A4D514C-2948-491A-8730-508DBD756314Q40133078-EC8A9177-C88F-4510-A0CF-095BA732583FQ48128190-87CA298D-A702-4264-BE04-406D692DA7C0Q50123294-F2D3FEBC-E2F7-4965-B703-792506F26FD9Q51731309-77AEB1C0-29C3-4B3E-9D44-81DAC7AC0E4AQ60301952-B68CC43E-4176-4D34-919C-BED637833F23Q60301953-2C815CBE-165A-4904-A236-3C26A6392516Q60949309-627F207E-6E73-45A6-917C-0138C442750CQ86646203-A65D2DA4-2C1F-4F58-89CE-3AF2DB0C4293Q86994233-28A0A45C-2C37-4F1F-88E1-9C80C106B73AQ88215968-69D3C233-7687-42A9-87FD-0F052B27A0A1Q89649101-795CDEAF-406F-4BD8-BA59-782B172B49FAQ90119359-7CC446C3-7EA7-469D-B4ED-8D32B2D5B61DQ91238751-DB26947D-3526-42EF-AC80-9D9988499E25Q91331105-694D6491-3455-4281-AE3A-39B1BCA50ACCQ91604676-86BDBCF6-5ABD-4542-A31F-91DE37255C25Q92442044-25B43979-400D-4324-A386-37A33A49BF22Q92706854-E35EB4B2-C7F0-4587-933F-26E6EC56E149
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
E Frison
@en
E Frison
@nl
type
label
E Frison
@en
E Frison
@nl
prefLabel
E Frison
@en
E Frison
@nl
P31
P496
0000-0001-5844-1886